Gonadorelin Acetate vs Triptorelin Acetate
Gonadorelin Acetate (GnRH analog) and Triptorelin Acetate (GnRH analog) are documented as co-studied in the PeptiDex library. This page puts the two entries side by side on class, molecular weight, half-life, origin, mechanism and studied research areas — every value taken from the entry it belongs to.
Why these two are co-studied
Cross-referenced for research context — not a usage or combination recommendation.
At a glance
| Attribute | Gonadorelin Acetate | Triptorelin Acetate |
|---|---|---|
| Compound class | GnRH analog | GnRH analog |
| Research category | Hormonal & Sexual Health | Hormonal & Sexual Health |
| Length (amino acids) | 10 amino acids | 10 amino acids |
| Molecular weight | ~1182 g/mol | ~1311 g/mol |
| Half-life | ~2-10 min (distribution); ~10-40 min (terminal) | ~3 hours (free peptide, IV); depot forms release over weeks to months |
| Origin | Gonadorelin is a synthetic form of the endogenous decapeptide gonadotropin-releasing hormone (GnRH, also called LHRH). Its acetate salt is used clinically in reproductive endocrinology. | Triptorelin is a synthetic decapeptide agonist analog of gonadotropin-releasing hormone (GnRH), in which a D-tryptophan substitution at position 6 increases potency and duration. It is marketed under names such as Trelstar and Decapeptyl. |
“Not documented” means the PeptiDex entry records no value for that field. Nothing on this page is estimated, and no figure is carried over from one compound to the other.
How Gonadorelin Acetate works
Gonadorelin is structurally identical to native GnRH and binds GnRH receptors on pituitary gonadotrophs, stimulating secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Because it is the native decapeptide with a short half-life, pulsatile administration mimics physiological GnRH release, whereas continuous exposure can downregulate the receptor. It is used diagnostically and to stimulate the hypothalamic-pituitary-gonadal axis.
How Triptorelin Acetate works
Triptorelin is a GnRH receptor superagonist; the D-Trp6 substitution enhances receptor affinity and metabolic stability. Acute administration transiently stimulates LH and FSH release, but sustained (continuous) exposure downregulates and desensitizes pituitary GnRH receptors, suppressing gonadotropin and downstream sex-steroid production. This 'medical castration' effect underlies its use in hormone-sensitive conditions.
Mechanistic descriptions reflect published research-literature understanding and are quoted from each compound's own entry. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
Where each one appears in the literature
The research contexts each entry documents. Listing a research area is not a claim of efficacy or a therapeutic indication, and the two lists are not scored against each other.
Gonadorelin Acetate
Triptorelin Acetate
What sets each apart
Gonadorelin Acetate
Gonadorelin is the native GnRH decapeptide with a short half-life, contrasting with triptorelin, a modified long-acting GnRH superagonist that produces sustained receptor downregulation.
Triptorelin Acetate
Triptorelin is a modified long-acting GnRH superagonist that suppresses the axis via receptor downregulation, opposite to the physiological stimulation from pulsatile native gonadorelin.
Frequently asked questions
What is gonadorelin?
Gonadorelin is synthetic gonadotropin-releasing hormone (GnRH), a decapeptide identical to the native hypothalamic sequence. It agonizes the pituitary GnRH receptor to trigger release of LH and FSH, making it a core research tool for probing the HPG axis.
Why must gonadorelin be given in pulses?
The GnRH receptor responds to pulsatile stimulation but desensitizes under continuous exposure, which paradoxically suppresses LH/FSH. Research protocols therefore administer gonadorelin intermittently (often modeling ~90-120 minute pulses) to sustain a gonadotropin response rather than shut it down.
How does gonadorelin differ from triptorelin?
Gonadorelin is native GnRH with a very short half-life, so it behaves as a pulsatile stimulus. Triptorelin is a modified super-agonist (D-Trp at position 6) with far greater potency and duration, which after an initial flare causes sustained receptor desensitization and downstream suppression.
What is triptorelin?
Triptorelin is a synthetic GnRH (gonadotropin-releasing hormone) super-agonist, a decapeptide analog of gonadorelin with D-tryptophan substituted at position 6. That substitution increases receptor affinity and resistance to enzymatic breakdown, giving it far greater potency and duration than native GnRH.
How does triptorelin affect the HPG axis?
An initial dose causes a transient flare of LH, FSH and sex-hormone release, but sustained or depot exposure desensitizes and downregulates pituitary GnRH receptors, producing profound downstream suppression of LH/FSH and sex hormones. It is studied in reproductive endocrinology and hormone-suppression models.
How does triptorelin differ from gonadorelin?
Gonadorelin is native GnRH with a very short half-life used for pulsatile stimulation, whereas triptorelin is a long-acting super-agonist whose continuous presence ultimately suppresses the axis. The practical difference is stimulation (gonadorelin) versus flare-then-suppression (triptorelin).
Answers are the ones published on each compound's own PeptiDex entry. They are educational summaries of research-literature context and are not medical advice.